Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
Avadel Pharmaceuticals (AVDL) Stock Forecast & Price Target
617 Followers
See the Price Targets and Ratings of:
AVDL Analyst Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AVDL Stock 12 Month Forecast
Average Price Target
$24.50
▲(50.77% Upside)
| Highest Price Target$29.00 | Average Price Target$24.50 | Lowest Price Target$20.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
05/09/24
Leerink Partners
Reiterated
03/04/24
Piper Sandler
Reiterated
03/04/24
Ladenburg Thalmann & Co.
$17.00
Buy
4.62%
Upside
Reiterated
11/09/23
Strong 3Q23 Revenues and Robust Pipeline Bolster Buy Rating on Avadel Pharmaceuticals: An Analysis of Kaplan's Recommendation
―
LifeSci Capital
―
Buy
―
Reiterated
05/08/24
Avadel Pharmaceuc als (Nasdaq: AVDL) management reported $27.2M and $25.7M in net revenue and gross profit for Lumryz in the first quarter 2024, respecv ely. The results beat revenue consensus for the quarter which stood at $25.9M. We are encouraged by the connued progress nong that more than 1,700 paen ts-inia ted therapy, up 500 paen ts from the latest update in January 2024. We note that this number is disnct from paen ts on therapy. It is important to acknowledge that some paen ts receive benefit from free drug programs and some disconnue treatment. The disconnua on rate remains numerically lower than what we see historically with twice-nightly products (<25% 1-month dropout rate).
Best Analysts Covering Avadel Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy AVDL and Sell After:
1 Month
3 Months
1 Year
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AVDL Analyst Recommendation Trends
Rating
Dec 23
Jan 24
Feb 24
Mar 24
May 24
Strong Buy
9
8
2
5
5
Buy
4
4
5
8
7
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
12
7
13
12
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
AVDL Financial Forecast
AVDL Stock Forecast FAQ
What is AVDL’s average 12-month price target, according to analysts?
Based on analyst ratings, Avadel Pharmaceuticals’s 12-month average price target is $24.50.
What is AVDL’s upside potential, based on the analysts’ average price target?
Avadel Pharmaceuticals has 50.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AVDL a Buy, Sell or Hold?
Avadel Pharmaceuticals has a conensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Avadel Pharmaceuticals’s price target?
The average price target for Avadel Pharmaceuticals is $24.50. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $29.00 ,the lowest forecast is $20.00. The average price target represents 50.77% Increase from the current price of $16.25.
The highest analyst price target is $29.00 ,the lowest forecast is $20.00. The average price target represents 50.77% Increase from the current price of $16.25.
What do analysts say about Avadel Pharmaceuticals?
Avadel Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of AVDL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.